Cleerly LABS vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by RhythmScience

AI Verdict

Cleerly LABS focuses on AI-powered analysis of coronary CT angiography (CCTA) to detect and characterize atherosclerosis and stenosis, providing insights for heart disease management based on imaging. In contrast, Rhythm360 is an integrated platform that unifies and interprets cardiac monitoring data from various devices to manage conditions like hypertension and heart failure, primarily streamlining remote patient monitoring. While both are cardiology AI tools, their distinct data inputs (imaging vs. monitoring) and primary functions make them adjacent rather than direct competitors.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary need is a detailed, AI-powered anatomical and pathological assessment of coronary arteries. This tool is ideal for precisely quantifying plaque burden, characterizing stenosis, and visualizing coronary anatomy in 3D to inform personalized treatment plans and track disease progression in patients with suspected or known coronary artery disease.

View Cleerly LABS →

Choose Rhythm360 if…

Choose Rhythm360 if your clinic requires a comprehensive, vendor-neutral platform to aggregate and manage continuous cardiac monitoring data from various devices. This solution is best suited for reducing alert fatigue, streamlining workflows, and automating billing for remote patient monitoring programs, particularly for patients with hypertension, heart failure, or arrhythmia requiring ongoing surveillance.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Rhythm360
Pricing Varies Flexible pricing model that scales with clinic size and platform usage.
Deployment Cloud, On-premise Cloud-based SaaS platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360's focus on unifying diverse cardiac monitoring data, AI-driven alert triage, and a HIPAA-compliant mobile application for clinicians suggests a design optimized for streamlining daily clinical workflows and reducing alert fatigue. Cleerly LABS, while offering powerful 3D visualization, is more specialized for CCTA analysis, which may require a more focused user interaction.

Clinical Value

Cleerly LABS

Cleerly LABS is FDA-cleared and provides comprehensive, AI-powered analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, aiming to establish a new standard of care for personalized heart disease management and potentially prevent heart attacks. While Rhythm360 offers significant value in managing existing conditions through data aggregation and alert reduction, Cleerly's diagnostic precision and preventative potential represent a more foundational clinical impact.

Pricing & Value

Tie

Cleerly LABS has a transparent, albeit high, per-analysis cost ($750-$1500), often requiring out-of-pocket payment, which can be a barrier to access. Rhythm360 uses a flexible SaaS model that scales with clinic size, but is noted as having 'premium pricing' without specific figures, making a direct value comparison difficult. Both present potential cost challenges, but for different reasons.

Enterprise Readiness

Rhythm360

Both tools are cloud-based, HIPAA compliant, and have BAAs. However, Rhythm360 demonstrates superior enterprise readiness through its broad bi-directional EHR integration with multiple major vendors (Epic, Cerner, etc.), vendor-neutral data aggregation from all major cardiac device OEMs, and automated CPT code documentation and billing, which are crucial for large-scale operational efficiency.

Innovation

Cleerly LABS

Cleerly LABS offers a more fundamental innovation by leveraging AI for FDA-cleared, comprehensive plaque assessment from CCTA, moving beyond traditional stenosis to characterize atherosclerosis and detect ischemia. This aims to create a new standard of care for CAD diagnosis and prevention. Rhythm360's AI for data aggregation and alert triage is innovative for workflow, but Cleerly's approach to redefining a diagnostic standard is a greater paradigm shift.

Support & Docs

Rhythm360

Rhythm360 offers a comprehensive support ecosystem, including a knowledge base with support documentation, the ability to create help tickets from within the platform, and an optional 24/7/365 oversight service by certified cardiac technicians. Cleerly LABS provides standard business-hour support with a focus on timely responses but lacks documented self-service resources or advanced operational support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Rhythm360
Primary Function/Focus AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Company Cleerly RhythmScience
Core Technology/Input AI-powered CCTA image analysis for comprehensive coronary plaque assessment and stenosis detection. Vendor-neutral data aggregation from various cardiac monitoring devices.
EHR Integration Integration with PACS, RIS, EHR via Cleerly Proxy. Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).
Alert Management/Insights Personalized heart disease risk assessment, tracking disease progression over time. AI-driven alert triage (80% faster response times, reduces alert fatigue), actionable insights for hypertension, heart failure, and rhythm management.
Billing/Coding Support Not specified Automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457).

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered, FDA-cleared software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. It focuses on identifying and tracking coronary artery disease (CAD) in patients who undergo CCTA, including those with acute or stable chest pain. Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. It is designed for ongoing management of patients with chronic cardiac conditions by aggregating data from implantable and external cardiac devices.
Cleerly LABS primarily analyzes coronary CT angiography (CCTA) images, integrating with PACS, RIS, and EHR systems via an on-site Cleerly Proxy for data transfer. Rhythm360 aggregates cardiac monitoring data from various vendor-neutral devices (e.g., Medtronic, Boston Scientific, Abbott, Biotronik) and offers bi-directional integration with major EHRs like Epic, Cerner, and Athenahealth, using API, HL7, XML, and PDF parsing.
Cleerly LABS is an FDA-cleared web-based software. Rhythm360 is an AI-powered integrated platform that unifies cardiac monitoring data, but the provided information does not explicitly state its FDA clearance status. However, it does integrate data from FDA-approved remote patient monitoring devices.
Cleerly LABS streamlines CCTA image analysis, providing comprehensive plaque assessment and stenosis detection, which can inform personalized heart disease management and track disease progression over time. Rhythm360 features AI-driven alert triage, which can lead to 80% faster response times and reduces alert fatigue by filtering non-actionable notifications and prioritizing clinically significant events.
Cleerly LABS aids in personalized heart disease management by detecting, quantifying, and characterizing atherosclerosis and stenosis, and allows for tracking disease progression over time. Rhythm360 explicitly offers features for hypertension management, heart failure management (including predictive algorithms and GDMT optimization), and rhythm management, with optional 24/7/365 oversight by certified cardiac technicians.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.